NCT01652937View on ClinicalTrials.gov

BIIB057 in Subjects With Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions
Rheumatoid Arthritis
Interventions
DRUG

BIIB057

Oral

DRUG

Placebo

Oral

Trial Locations (3)

R3C 3J5

Research Site, Winnipeg

E2E 4J8

Research Site, Quispamsis

M9W 4L6

Research Site, Toronto

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY